142 related articles for article (PubMed ID: 24692703)
1. Endoplasmic reticulum stress response as a possible mechanism of cyclooxygenase-2-independent anticancer effect of celecoxib.
Cha W; Park SW; Kwon TK; Hah JH; Sung MW
Anticancer Res; 2014 Apr; 34(4):1731-5. PubMed ID: 24692703
[TBL] [Abstract][Full Text] [Related]
2. Effects of celecoxib treatment over the AKT pathway in head and neck squamous cell carcinoma.
Abrahão AC; Giudice FS; Sperandio FF; Pinto Junior Ddos S
J Oral Pathol Med; 2013 Nov; 42(10):793-8. PubMed ID: 23679684
[TBL] [Abstract][Full Text] [Related]
3. Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib.
Kardosh A; Golden EB; Pyrko P; Uddin J; Hofman FM; Chen TC; Louie SG; Petasis NA; Schönthal AH
Cancer Res; 2008 Feb; 68(3):843-51. PubMed ID: 18245486
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib inhibits cell proliferation through the activation of ERK and p38 MAPK in head and neck squamous cell carcinoma cell lines.
Park SW; Kim HS; Hah JW; Jeong WJ; Kim KH; Sung MW
Anticancer Drugs; 2010 Oct; 21(9):823-30. PubMed ID: 20717005
[TBL] [Abstract][Full Text] [Related]
5. Hyperoxia and interferon-γ-induced injury in developing lungs occur via cyclooxygenase-2 and the endoplasmic reticulum stress-dependent pathway.
Choo-Wing R; Syed MA; Harijith A; Bowen B; Pryhuber G; Janér C; Andersson S; Homer RJ; Bhandari V
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):749-57. PubMed ID: 23470621
[TBL] [Abstract][Full Text] [Related]
6. Combining CAL-101 with Celecoxib Enhances Apoptosis of EBV-transformed B-Cells Through MAPK-induced ER Stress.
Park GB; Hur DY; Kim D
Anticancer Res; 2015 May; 35(5):2699-708. PubMed ID: 25964548
[TBL] [Abstract][Full Text] [Related]
7. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells.
Kim SH; Hwang CI; Juhnn YS; Lee JH; Park WY; Song YS
Carcinogenesis; 2007 Jan; 28(1):223-31. PubMed ID: 17166886
[TBL] [Abstract][Full Text] [Related]
8. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
Liu X; Yue P; Zhou Z; Khuri FR; Sun SY
J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759
[TBL] [Abstract][Full Text] [Related]
9. RU486 Induces Pro-Apoptotic Endoplasmic Reticulum Stress Through the Induction of CHOP Expression by Enhancing C/EBPδ Expression in Human Renal Carcinoma Caki Cells.
Jang JH; Min KJ; Kim S; Park JW; Kwon TK
J Cell Biochem; 2016 Feb; 117(2):361-9. PubMed ID: 26174226
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP.
He Q; Luo X; Jin W; Huang Y; Reddy MV; Reddy EP; Sheikh MS
Oncogene; 2008 Apr; 27(18):2656-60. PubMed ID: 17968315
[TBL] [Abstract][Full Text] [Related]
11. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
[TBL] [Abstract][Full Text] [Related]
12. GADD153 mediates celecoxib-induced apoptosis in cervical cancer cells.
Kim SH; Hwang CI; Park WY; Lee JH; Song YS
Carcinogenesis; 2006 Oct; 27(10):1961-9. PubMed ID: 16597647
[TBL] [Abstract][Full Text] [Related]
13. Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib.
Pyrko P; Kardosh A; Liu YT; Soriano N; Xiong W; Chow RH; Uddin J; Petasis NA; Mircheff AK; Farley RA; Louie SG; Chen TC; Schönthal AH
Mol Cancer Ther; 2007 Apr; 6(4):1262-75. PubMed ID: 17431104
[TBL] [Abstract][Full Text] [Related]
14. Sequential treatment of HPV E6 and E7-expressing TC-1 cells with bortezomib and celecoxib promotes apoptosis through p-p38 MAPK-mediated downregulation of cyclin D1 and CDK2.
Kim JE; Lee JI; Jin DH; Lee WJ; Park GB; Kim S; Kim YS; Wu TC; Hur DY; Kim D
Oncol Rep; 2014 May; 31(5):2429-37. PubMed ID: 24627094
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
Kim SH; Kim SH; Song YC; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells.
Huang KH; Kuo KL; Chen SC; Weng TI; Chuang YT; Tsai YC; Pu YS; Chiang CK; Liu SH
PLoS One; 2012; 7(3):e33615. PubMed ID: 22438966
[TBL] [Abstract][Full Text] [Related]
17. 2,5-Dimethyl-celecoxib inhibits cell cycle progression and induces apoptosis in human leukemia cells.
Sobolewski C; Rhim J; Legrand N; Muller F; Cerella C; Mack F; Chateauvieux S; Kim JG; Yoon AY; Kim KW; Dicato M; Diederich M
J Pharmacol Exp Ther; 2015 Nov; 355(2):308-28. PubMed ID: 26330537
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib inhibits interleukin-12 alphabeta and beta2 folding and secretion by a novel COX2-independent mechanism involving chaperones of the endoplasmic reticulum.
Alloza I; Baxter A; Chen Q; Matthiesen R; Vandenbroeck K
Mol Pharmacol; 2006 May; 69(5):1579-87. PubMed ID: 16467190
[TBL] [Abstract][Full Text] [Related]
19. The novel NF-κB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism.
Lampiasi N; Azzolina A; Umezawa K; Montalto G; McCubrey JA; Cervello M
Cancer Lett; 2012 Sep; 322(1):35-44. PubMed ID: 22343223
[TBL] [Abstract][Full Text] [Related]
20. Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling.
Kim N; Kim CH; Ahn DW; Lee KS; Cho SJ; Park JH; Lee MK; Kim JS; Jung HC; Song IS
J Gastroenterol Hepatol; 2009 Mar; 24(3):480-7. PubMed ID: 18823436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
